A prospective, non-interventional study in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib for 2 years (PARROTFISH)First published 05/04/2022 Last updated 14/03/2024 EU PAS number: EUPAS46020StudyOngoingDownload as PDF